Hui Liu

发表

Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis.

Jun Liu, Hongbin Sun, Gan Sun, 2022, Journal of medicinal chemistry.

A Review of the Pharmacological Properties of Psoralen

Cheng Peng, Hui Liu, Miao Wang, 2020, Frontiers in Pharmacology.

N-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's Disease.

W. Li, Wenyuan Liu, F. Feng, 2022, Journal of medicinal chemistry.

Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds

F. Feng, Lei Wang, Yijun Liu, 2023, Medicinal research reviews.

Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.

Hongbin Sun, Gan Sun, Xin Liu, 2023, Journal of medicinal chemistry.

Syntheses, Characterizations, and Inhibition Activities Against Coxsackievirus B3 of Iodobenzoic Hydrazide Functionalized Hexamolybdates

K. Hu, Hui Liu, Long-Sheng Wang, 2022, Frontiers in Chemistry.

Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer's Disease.

Lei Wang, Haopeng Sun, Hui Liu, 2023, ACS chemical neuroscience.

A Practical and High‐Affinity Fluorescent Probe for Butyrylcholinesterase: A Good Strategy for Binding Affinity Characterization

Lei Wang, Yueqing Li, Xin Lu, 2022, Chinese journal of chemistry.